ArticleCurrent microbiology2026
Selective Carbohydrate Modulation Enhances BLIS-Mediated Bioprotection Against Multidrug-Resistant Foodborne Pathogens During Vegetable Fermentation.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Lactic acid bacteria (LAB) play a pivotal role in food fermentation by shaping microbial ecosystems and enhancing product safety through the production of antimicrobial metabolites. This study investigated the selective utilization of indigestible polysaccharides extracted from Cordyceps militaris (IPC) and their application in combination with a bacteriocin-like inhibitory substance (BLIS)-producing Leuconostoc mesenteroides AHL9a starter culture during mustard green fermentation. IPC selectively promoted the growth of Le. mesenteroides AHL9a, reaching 8.91 log CFU/mL after 24 h, and significantly enhanced BLIS production compared with conventional carbohydrates. The BLIS exhibited broad-spectrum inhibitory activity against multidrug-resistant foodborne pathogens, including Escherichia coli Mp01, Salmonella enterica serovar Typhimurium Dk05, Bacillus cereus Nt06, and Staphylococcus aureus Ke08, and remained stable across a wide pH range (2.0-12.0) and temperatures relevant to food processing (up to 100 °C). When applied as a starter culture in mustard green fermentation, both AHL9a alone and AHL9a supplemented with IPC accelerated LAB dominance, achieving populations of 7.56-7.78 log CFU/g by day 10, while more effectively reducing aerobic bacteria and eliminating coliforms compared with spontaneous fermentation. IPC supplementation further strengthened microbial control and enhanced organic acid production, resulting in increased levels of L-lactate (2.60 g/L), acetate (7.01 g/L), butyrate (10.13 g/L), and propionate (5.67 g/L). These findings demonstrate that selective carbohydrate supplementation with IPC can modulate BLIS production and enhance bioprotection during vegetable fermentation. This study highlights the potential of integrating food-derived BLIS-producing starter cultures with selectively utilized carbohydrates to improve the safety and reliability of fermented vegetable products.
Indexed as
Identifiers
42191890What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.